Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

British Medical Groups Express Concern About Inclisiran Rollout

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

Statins Underprescribed in PAD Before and After Interventions

News Daily News

Statins Underprescribed in PAD Before and After Interventions

December 03, 2021

TCTMD’s Top 10 Most Popular Stories for November 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

November 30, 2021

Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis

News Daily News

Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis

October 27, 2021

Polygenic Risk Score IDs People at Risk for Early MI, Death

News Daily News

Polygenic Risk Score IDs People at Risk for Early MI, Death

October 26, 2021

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

Heterozygous FH Diagnosed Late, Remains Undertreated

News Daily News

Heterozygous FH Diagnosed Late, Remains Undertreated

Michael O'Riordan

September 13, 2021

Statins Positively Alter Coronary Plaque Composition

News Daily News

Statins Positively Alter Coronary Plaque Composition

Michael O'Riordan

August 23, 2021

OMT Boosts Survival in Revascularized Patients at 10 Years

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

Gatekeeper CTA Strategy in Stable Chest Pain Still Needs Honing

News Daily News

Gatekeeper CTA Strategy in Stable Chest Pain Still Needs Honing

Yael L. Maxwell

March 08, 2021

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.